Noxafil
Merck moves tropical disease drug into phase II
June 25, 2010Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease
Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …
Latest content
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
